MATERIALS AND METHODS.
We have employed DD-PCR techniques to screen novel genes whose expression is differentially regulated by Th1 and Th2 cytokines in human lymphocytes. One of the selected DD-PCR products was adenine nucleotide translocator(ANT3). The mRNA expression pattern by various Th1 and Th2 cytokines was analyzed by Northern blot and RT-PCR in B, T, and monocytic cells. The apoptosis study was performed using DNA fragmentation analysis and DiOC 6 and PI staining by flow cytometry.
RESULTS. ANT(3) was identified as a gene induced by IL-4 and counter-regulated by IFN-r , a prototypic Th2 and Th1 cytokine. Such counter-regulation was found primarily in T cells, but not in B cells or monocytes. We observed that under the condition in which IL-4 rescued CD4+ lymphocytes from dexamethasone-induced apoptosis, there was a concomittant increase in the ANT mRNA expression by IL-4. While IL-4 induced PI3K and MAPK activity in these cells, inhibitors of PI3K and MAPK both effectively suppressed the IL-4-induced lymphocyte survival and ANT expression. The up-regulation of ANT mRNA level by IL-4 seems to involve, at least in part, an increase in ANT mRNA stability, since the effect of IL-4 was more prominently observed upon using 3'UTR probe than the coding region probe of ANT. In addition, IGF-1, which activates PI3K and MAPK via IRS-1, not only induced the ANT gene expression, but also agumented the IL-4-induced ANT mRNA up-regulation in T cells.
CONCLUSION.
While the function of ANT has been well recognized for maintaining cellular energy supply and metabolitic regulation, recent studies proposed a role of ANT as an apoptotic regulator by interacting with Bax. Our present findings indicate that the IL-4-induced lymphocyte rescue from apoptosis is mediated via PI3K and MAPK, down-stream effectors of IRS-1/2 through the up-regulation of ANT mRNA stability, suggesting a role of ANT in the IL-4-mediated Th cell survival.
